CL2019001832A1 - Compuestos medicinales y suplementos nutricionales. - Google Patents
Compuestos medicinales y suplementos nutricionales.Info
- Publication number
- CL2019001832A1 CL2019001832A1 CL2019001832A CL2019001832A CL2019001832A1 CL 2019001832 A1 CL2019001832 A1 CL 2019001832A1 CL 2019001832 A CL2019001832 A CL 2019001832A CL 2019001832 A CL2019001832 A CL 2019001832A CL 2019001832 A1 CL2019001832 A1 CL 2019001832A1
- Authority
- CL
- Chile
- Prior art keywords
- nutritional supplements
- medicinal compounds
- carriers
- various
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Botany (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762441908P | 2017-01-03 | 2017-01-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019001832A1 true CL2019001832A1 (es) | 2020-01-31 |
Family
ID=62790943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019001832A CL2019001832A1 (es) | 2017-01-03 | 2019-07-02 | Compuestos medicinales y suplementos nutricionales. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20190336472A1 (https=) |
| EP (1) | EP3565539A4 (https=) |
| JP (3) | JP7281815B2 (https=) |
| KR (1) | KR20190103302A (https=) |
| CN (1) | CN110121337A (https=) |
| AU (2) | AU2018206564B2 (https=) |
| BR (1) | BR112019013743A2 (https=) |
| CA (1) | CA3049226A1 (https=) |
| CL (1) | CL2019001832A1 (https=) |
| CO (1) | CO2019008176A2 (https=) |
| EA (1) | EA201991641A1 (https=) |
| IL (1) | IL267831A (https=) |
| MX (1) | MX2019007968A (https=) |
| WO (1) | WO2018129097A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11180781B2 (en) * | 2016-08-21 | 2021-11-23 | Insectergy, Llc | Biosynthetic cannabinoid production methods |
| EP3928776B1 (en) | 2016-04-22 | 2025-11-12 | Spoke Sciences, Inc. | Fast-acting plant-based medicinal compounds and nutritional supplements |
| EA201892396A1 (ru) | 2016-12-02 | 2019-04-30 | Ресептор Лайф Сайенсиз, Инк. | Быстродействующие растительные лекарственные соединения и биологически активные добавки |
| KR20190103302A (ko) * | 2017-01-03 | 2019-09-04 | 리셉터 홀딩스, 인크. | 의약 화합물 및 영양 보충제 |
| WO2019144221A1 (en) * | 2018-01-29 | 2019-08-01 | Solantech Inc. | Methods of treating and/or preventing bedsores using nabilone |
| KR20210116432A (ko) * | 2018-10-10 | 2021-09-27 | 틸레이, 인크. | 화학요법으로 유발된 메스꺼움 및 구토 치료를 위한 방법 및 제형 |
| AU2019385420A1 (en) * | 2018-11-19 | 2021-07-08 | Spoke Sciences, Inc. | N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions |
| US11759447B1 (en) | 2019-06-26 | 2023-09-19 | RCR BioPharma | Compound and method for treating diseases and disorders |
| EP3946262B1 (en) | 2019-08-30 | 2024-07-31 | Evie Sa | Loaded granules, their process of production and their uses |
| JP2023505351A (ja) | 2019-12-09 | 2023-02-08 | ニコベンチャーズ トレーディング リミテッド | 口腔用組成物のための薬剤 |
| US12171872B2 (en) | 2019-12-09 | 2024-12-24 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
| CN113040337B (zh) * | 2021-04-22 | 2022-12-09 | 四川大学 | 一种熏肉制品及其制备方法 |
| WO2024253228A1 (ko) * | 2023-06-09 | 2024-12-12 | 주식회사 메타파인즈 | 악액질 및 근손실의 예방 또는 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001523221A (ja) | 1996-09-01 | 2001-11-20 | ファーモス コーポレイション | 親油性物質の促進された生物学的利用能のための固形共沈物 |
| AU2002352974A1 (en) * | 2001-11-29 | 2003-06-10 | Emisphere Technologies, Inc. | Formulations for oral administration of cromolyn sodium |
| US9308175B2 (en) | 2006-09-15 | 2016-04-12 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| NZ609356A (en) | 2010-11-25 | 2014-10-31 | Aop Orphan Pharmaceuticals Ag | Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin |
| WO2013032934A1 (en) * | 2011-08-26 | 2013-03-07 | Aegis Therapeutics, Llc | Compositions and methods thereof for oral administration of drugs |
| CA2845443A1 (en) * | 2014-03-04 | 2015-09-04 | Pharmascience Inc. | Orally disintegrating tablet of nabilone and method of manufacturing |
| EP3928776B1 (en) | 2016-04-22 | 2025-11-12 | Spoke Sciences, Inc. | Fast-acting plant-based medicinal compounds and nutritional supplements |
| KR20190103302A (ko) | 2017-01-03 | 2019-09-04 | 리셉터 홀딩스, 인크. | 의약 화합물 및 영양 보충제 |
-
2018
- 2018-01-03 KR KR1020197022846A patent/KR20190103302A/ko not_active Ceased
- 2018-01-03 EA EA201991641A patent/EA201991641A1/ru unknown
- 2018-01-03 MX MX2019007968A patent/MX2019007968A/es unknown
- 2018-01-03 AU AU2018206564A patent/AU2018206564B2/en active Active
- 2018-01-03 JP JP2019536222A patent/JP7281815B2/ja active Active
- 2018-01-03 CA CA3049226A patent/CA3049226A1/en active Pending
- 2018-01-03 EP EP18736204.1A patent/EP3565539A4/en not_active Withdrawn
- 2018-01-03 CN CN201880005658.8A patent/CN110121337A/zh active Pending
- 2018-01-03 US US16/474,480 patent/US20190336472A1/en not_active Abandoned
- 2018-01-03 BR BR112019013743-2A patent/BR112019013743A2/pt not_active Application Discontinuation
- 2018-01-03 WO PCT/US2018/012261 patent/WO2018129097A1/en not_active Ceased
-
2019
- 2019-07-02 CL CL2019001832A patent/CL2019001832A1/es unknown
- 2019-07-03 IL IL267831A patent/IL267831A/en unknown
- 2019-07-29 CO CONC2019/0008176A patent/CO2019008176A2/es unknown
-
2022
- 2022-06-07 US US17/834,798 patent/US20230293479A1/en not_active Abandoned
-
2023
- 2023-02-10 JP JP2023018922A patent/JP7466238B2/ja active Active
-
2024
- 2024-02-20 AU AU2024201078A patent/AU2024201078A1/en active Pending
- 2024-03-25 JP JP2024047771A patent/JP2024075724A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7281815B2 (ja) | 2023-05-26 |
| AU2018206564B2 (en) | 2023-12-07 |
| EP3565539A4 (en) | 2020-08-12 |
| CO2019008176A2 (es) | 2019-08-20 |
| US20230293479A1 (en) | 2023-09-21 |
| EA201991641A1 (ru) | 2020-03-10 |
| CN110121337A (zh) | 2019-08-13 |
| IL267831A (en) | 2019-09-26 |
| MX2019007968A (es) | 2019-12-05 |
| JP7466238B2 (ja) | 2024-04-12 |
| JP2020503357A (ja) | 2020-01-30 |
| KR20190103302A (ko) | 2019-09-04 |
| US20190336472A1 (en) | 2019-11-07 |
| BR112019013743A2 (pt) | 2020-01-21 |
| AU2018206564A1 (en) | 2019-08-15 |
| CA3049226A1 (en) | 2018-07-12 |
| WO2018129097A1 (en) | 2018-07-12 |
| JP2024075724A (ja) | 2024-06-04 |
| EP3565539A1 (en) | 2019-11-13 |
| AU2024201078A1 (en) | 2024-03-07 |
| JP2023071697A (ja) | 2023-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001832A1 (es) | Compuestos medicinales y suplementos nutricionales. | |
| CO2018011299A2 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción | |
| CO2019005565A2 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción | |
| CO2020005349A2 (es) | Composiciones de hierbas con mejor biodisponibilidad | |
| MX2020003573A (es) | Formulaciones cannabinoides sinteticas y a base de plantas de inicio rapido y accion prolongada. | |
| MX2021003939A (es) | Inhibidores de la interaccion de menina-leucemia de linaje mixto. | |
| CO2019009258A2 (es) | Administración rápida y controlada de composiciones con efectos séquito restaurados | |
| MX2018004515A (es) | Agentes de anticuerpo especificos para cd19 humano y usos de los mismos. | |
| BR112018012707A2 (pt) | inibidores da interação de menin-mll | |
| CL2017003404A1 (es) | Compuestos antibacterianos | |
| MX2019007030A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| MX2017015467A (es) | Metodos y composiciones para inhibir la interaccion de menina con proteinas de mll. | |
| MX388858B (es) | Reducción de la viscosidad de formulaciones farmacéuticas | |
| MX2018010971A (es) | Compuestos y métodos para modular la tirosina cinasa de bruton. | |
| CO2020006907A2 (es) | Péptidos antimicrobianos y métodos para usarlos | |
| AR101414A1 (es) | Derivados de pirrolidinona como inhibidores de metap-2 | |
| EA202190633A1 (ru) | Лекарственные формы для применения в педиатрии, способы получения и применения | |
| EA201791716A1 (ru) | Фармацевтический состав | |
| DOP2018000034A (es) | Combinaciones de un anticuerpo ox40 y un modulador de tlr4 y usos de las mismas | |
| ECSP15009928A (es) | Producto de pienso y/o ingrediente de pienso | |
| MX2019005340A (es) | Composiciones y metodos de alimento para mascotas. | |
| EA201891256A1 (ru) | Индивидуальная активация в подгруппе источников | |
| BR112018001719A2 (pt) | composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. | |
| EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| AR105728A1 (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina |